159 related articles for article (PubMed ID: 11165095)
1. Solubilization of tropicamide by hydroxypropyl-beta-cyclodextrin and water-soluble polymers: in vitro/in vivo studies.
Cappello B; Carmignani C; Iervolino M; Immacolata La Rotonda M; Fabrizio Saettone M
Int J Pharm; 2001 Feb; 213(1-2):75-81. PubMed ID: 11165095
[TBL] [Abstract][Full Text] [Related]
2. Ophthalmic vehicles containing polymer-solubilized tropicamide: "in vitro/in vivo" evaluation.
Carmignani C; Rossi S; Saettone MF; Burgalassi S
Drug Dev Ind Pharm; 2002 Jan; 28(1):101-5. PubMed ID: 11858520
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of the mydriatic response to tropicamide by bioadhesive polymers.
Herrero-Vanrell R; Fernandez-Carballido A; Frutos G; Cadórniga R
J Ocul Pharmacol Ther; 2000 Oct; 16(5):419-28. PubMed ID: 11110033
[TBL] [Abstract][Full Text] [Related]
4. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
[TBL] [Abstract][Full Text] [Related]
5. Potential Use of Cyclodextrin Complexes for Enhanced Stability, Anti-inflammatory Efficacy, and Ocular Bioavailability of Loteprednol Etabonate.
Soliman OAE; Mohamed EAM; El-Dahan MS; Khatera NAA
AAPS PharmSciTech; 2017 May; 18(4):1228-1241. PubMed ID: 27469220
[TBL] [Abstract][Full Text] [Related]
6. Effect of water-soluble polymers on naproxen complexation with natural and chemically modified beta-cyclodextrins.
Faucci MT; Mura P
Drug Dev Ind Pharm; 2001 Oct; 27(9):909-17. PubMed ID: 11763468
[TBL] [Abstract][Full Text] [Related]
7. Development of topically effective formulations of acetazolamide using HP-beta-CD-polymer co-complexes.
Kaur IP; Kapil M; Smitha R; Aggarwal D
Curr Drug Deliv; 2004 Jan; 1(1):65-72. PubMed ID: 16305371
[TBL] [Abstract][Full Text] [Related]
8. Considerations in the use of hydroxypropyl-beta-cyclodextrin in the formulation of aqueous ophthalmic solutions of hydrocortisone.
Bary AR; Tucker IG; Davies NM
Eur J Pharm Biopharm; 2000 Sep; 50(2):237-44. PubMed ID: 10962233
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin.
Wu C; Qi H; Chen W; Huang C; Su C; Li W; Hou S
Yakugaku Zasshi; 2007 Jan; 127(1):183-91. PubMed ID: 17202799
[TBL] [Abstract][Full Text] [Related]
10. The effect of a modified beta-cyclodextrin, SBE4-beta-CD, on the aqueous stability and ocular absorption of pilocarpine.
Järvinen K; Järvinen T; Thompson DO; Stella VJ
Curr Eye Res; 1994 Dec; 13(12):897-905. PubMed ID: 7720398
[TBL] [Abstract][Full Text] [Related]
11. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.
Alexanian C; Papademou H; Vertzoni M; Archontaki H; Valsami G
J Pharm Pharmacol; 2008 Nov; 60(11):1433-9. PubMed ID: 18957163
[TBL] [Abstract][Full Text] [Related]
12. Solubilization of a naphthoquinone derivative by hydroxypropyl-beta-cyclodextrin (HP-beta-CD) and polyvinylpyrrolidone (PVP-K30). The influence of PVP-K30 and pH on solubilizing effect of HP-beta-CD.
Granero G; de Bertorello MM; Longhi M
Boll Chim Farm; 2002; 141(1):63-6. PubMed ID: 12064060
[TBL] [Abstract][Full Text] [Related]
13. Optimized transdermal delivery of ketoprofen using pH and hydroxypropyl-beta-cyclodextrin as co-enhancers.
Sridevi S; Diwan PV
Eur J Pharm Biopharm; 2002 Sep; 54(2):151-4. PubMed ID: 12191685
[TBL] [Abstract][Full Text] [Related]
14. The effects of water-soluble cyclodextrins on the histological integrity of the rat nasal mucosa.
Asai K; Morishita M; Katsuta H; Hosoda S; Shinomiya K; Noro M; Nagai T; Takayama K
Int J Pharm; 2002 Oct; 246(1-2):25-35. PubMed ID: 12270606
[TBL] [Abstract][Full Text] [Related]
15. Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat.
Trapani G; Latrofa A; Franco M; Pantaleo MR; Sanna E; Massa F; Tuveri F; Liso G
J Pharm Sci; 2000 Nov; 89(11):1443-51. PubMed ID: 11015689
[TBL] [Abstract][Full Text] [Related]
16. Study on the inclusion complexes of bromazepam with beta- and beta-hydroxypropyl-cyclodextrins.
Archontaki HA; Vertzoni MV; Athanassiou-Malaki MH
J Pharm Biomed Anal; 2002 May; 28(3-4):761-9. PubMed ID: 12008156
[TBL] [Abstract][Full Text] [Related]
17. Interaction of iodine with 2-hydroxypropyl-alpha-cyclodextrin and its bactericidal activity.
Tomono K; Goto H; Suzuki T; Ueda H; Nagai T; Watanabe J
Drug Dev Ind Pharm; 2002 Nov; 28(10):1303-9. PubMed ID: 12476876
[TBL] [Abstract][Full Text] [Related]
18. Daidzein/cyclodextrin/hydrophilic polymer ternary systems.
Borghetti GS; Pinto AP; Lula IS; Sinisterra RD; Teixeira HF; Bassani VL
Drug Dev Ind Pharm; 2011 Aug; 37(8):886-93. PubMed ID: 21247375
[TBL] [Abstract][Full Text] [Related]
19. Co-administration of a water-soluble polymer increases the usefulness of cyclodextrins in solid oral dosage forms.
Savolainen J; Järvinen K; Taipale H; Jarho P; Loftsson T; Järvinen T
Pharm Res; 1998 Nov; 15(11):1696-701. PubMed ID: 9833990
[TBL] [Abstract][Full Text] [Related]
20. Itraconazole formulation studies of the melt-extrusion process with mixture design.
Rambali B; Verreck G; Baert L; Massart DL
Drug Dev Ind Pharm; 2003 Jul; 29(6):641-52. PubMed ID: 12889782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
